NASDAQ (USD): Athira Pharma, Inc. (ATHA)
Last Price
0.606
Today's Change
+0.178 (41.58%)
Day's Change
0.548 - 0.747
Trading Volume
238,606,006
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Tencent-backed Airwallex Seeks Funding at US$6b Value
2
Gold Demand Tops US$100b as Western Investors Charge in
3
US Pending Home Sales Gain Most Since Summer 2020
4
VinFast Gets US$1b Funding Led by Emirates Driving
5
US Hiring in ADP Data Rises to Fastest Pace in More Than a Year
#
Stock
Score
DJT
Trump Media & Technology Group Corp.
META
Meta Platforms, Inc.
MSFT
Microsoft Corporation
800
LLY
Eli Lilly and Company
750
TSM
Taiwan Semiconductor Manufacturing Company Limited
6
GOOGL
Alphabet Inc.
550
7
BABA
Alibaba Group Holding Limited
8
AAPL
Apple Inc.
9
BOH
Bank of Hawaii Corporation
500
10
AGN
Last
Change
Volume
ATHA
+0.178
SQQQ
7.44
-0.16
214,009,438
GSAT
1.39
+0.34
198,847,029
NVDA
135.37
+2.61
190,125,323
ELAB
0.029
-0.03
189,188,675
INTC
23.20
+1.68
166,757,862
ENSC
0.65
+0.074
142,614,700
LMDX
0.016
-0.018
120,553,903
LILM
0.209
-0.334
112,784,715
SMCI
26.05
-3.06
99,983,310
BRK-A
678,000.00
+1,040.50
1,274
BKNG
4,749.11
+72.86
480,921
WAT
387.21
+64.099
1,863,973
MDGL
319.58
+60.24
2,925,820
MTD
1,342.09
+50.34
163,995
CHTR
366.49
+38.88
4,211,595
CVCO
446.72
+36.92
77,102
TEAM
224.35
+35.81
9,538,933
MCK
526.34
+25.75
1,461,794
POWL
279.33
+24.35
582,356
MELI
1,629.32
-188.66
1,851,535
MPWR
759.30
-160.51
2,985,808
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
SEB
2,669.14
-96.87
4,341
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
547.51
-70.00
4,067,959
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....